Highlights from the 2018 FLASCO Fall Session


Thank you for your participation during the 2018 FLASCO Fall Session.  Your involvement and contagious enthusiasm was a key component to another successful program!



Friday Evening ~ Caring for Every Patient, Learning from Every Patient

Keynote Speaker ~ Monica M. Bertagnolli, MD, ASCO President


Saturday | General Session ~ Precision Medicine CE

Moderator: Eric Harris, DO, Florida Cancer Specialists and Research Institute
Speaker: Howard McLeod, PharmD, Moffitt Cancer Center/University of South Florida


Difficult Conversations

Beth Sussman | Executive Coach


Panel Questions


Morning Nursing Tracks

Beat the Cancer, Save Your Heart

Natalee Roper, RN,BSN,CHPN | Moffitt Cancer Center

Cathy Elstner RN, BSN | Moffitt Cancer Center

Navigating Patients: Understanding Clinical Trials

Christin Hart, RN, BSN, OCN | Florida Hospital Cancer Institute


Beth Davison, MSN, APRN, CNM | The Leukemia & Lymphoma Society


Afternoon Nursing Tracks


Supportive Care Throughout the Cancer Journey

Ana Rosa Espinosa, DNP, MBA, RN, OCN | Memorial Cancer Institute/Memorial Healthcare System


Palliative Care – Mayra Lima, APRN, MSN, FNP-C | Sylvester Comprehensive Cancer Center/University of Miami


Pain Management – Ana Garcia, APRN, MSN, FNP | Memorial Cancer Institute, Memorial
Healthcare System


Survivorship – Jessica McMillan, DNP, FNP, APRN-BC | Mayo Clinic Florida


Shaping the Future of Healthcare through Nursing

Andrea Uitti, DNP, RN | Florida Cancer for Nursing & Florida Action Coalition

Multi-Disciplinary Morning Tracks


Neoadjuvant Breast Cancer

Surgical –Stephanie A. Valente, DO, FACS | Cleveland Clinic Ohio


Radiation – Amber Orman, MD | Florida Hospital/University of Central Florida


Case Study – Sofia Palacio, MD | Jackson Memorial Hospital/University of Miami Fellowship Program


Multi-Disciplinary Afternoon Tracks


CLL: New and Projected Breakthroughs

Jan A. Burger, MD, PhD | MD Anderson Cancer Center, University of Texas


Case Study – Sonikpreet Aulakh, MD | Mayo Clinic Florida Fellowship Program


Case Study – Jeremy Ramdial, MD | Jackson Memorial Hospital/University of Miami Fellowship Program


Medical – Jingsong Zhang, MD, PhD | Moffitt Cancer Center


Pathology – Jasreman Dhillon, MD | Moffitt Cancer Center

Check back soon for this presentation.


Case Study – Brittany Rogers, MD | University of Florida Fellowship Program

Morning Pharmacy Tracks

Oral Oncolytics

Moderator: Ray Bailey, RPh | Florida Cancer Specialists Rx to Go


Medical Marijuana

Victoria Robinson, PharmD, BCOP | Emory University Hospital Midtown

Marcos Rejtman, DO, HMDC | Memorial Cancer Institute, Memorial Healthcare System

Afternoon Pharmacy Tracks

Revenue Integrity

Moderator: Dina Dumercy McHenry, PharmD, BCOP BCPS | Miami Cancer Institute, Baptist Hospital of Miami

Jorge García, PharmD, MS, MHA, MBA, FACHE | Miami Cancer Institute, Baptist Hospital of Miami

Patient Assistance Best Practices

Sarah Francis, PharmD, BCOP | Jackson Memorial Hospital

Changes in Oncology Clinical Trials Landscape

Anay Moscu, PharmD, BCPS, BCOP | Moffitt Cancer Center

Please check back soon for this presentation.

Poster Presentations

  • Candice Baldeo, MBBS, MD ~ Investigating the impact of Physical Activity in Autologous Stem Cell Recipients on QOL Scores during Hospitalization
  • Dana Drzayich Antol ~ Advanced care planning and selection of therapy: Influence on hospitalization for patients with metastatic lung cancer
  • Shohreh Eliaszadeh, MD ~ Biomarker Testing Survey for Microsatellite Instability/Mismatch Repair
  • Reima El Naili, MD ~ Biomarker Testing Survey for NSCC: The role PD-L1 inhibitors testing in clinical practice
  • Madiha Iqbal, MBBS, MD ~ Novel dual-affinity BTK/PI3Kγ overcome ibrutinib-resistance in preclinical models of Waldenström Macroglobulinemia
  • Jeffrey Trocio ~ Real-world clinical outcomes in patients treated with first-line palbociclib in combination with an endocrine partner at two years post-approval
  • Jeffrey Trocio ~ Real-world treatment patterns and clinical outcomes stratified by age, in women with HR+/HER2- advanced/metastatic breast cancer receiving palbociclib combination therapy
  • Jennifer Sibley, DNP ~ CheckMate 816: a phase 3 trial of neoadjuvant nivolumab plus ipilimumab or chemotherapy vs chemotherapy in early-stage NSCLC
  • Sharad Khurana, MD ~ Inositol Hexaphosphate (IP6) Plus Inositol Induced Complete Remission In Stage IV Melanoma: A Case Report
  • Martin Gutierrez, MD ~ Real world incidence, severity and timing of adverse events among patients with metastatic non-small cell lung cancer receiving second-line immuno-oncology therapy vs chemotherapy
  • Monica Chatwal, MD ~ Initial tumor flare or mixed tumor response following single PD-1 vs. dual PD-1/CTLA-4 blockade in non-small cell lung cancer (NSCLC)
  • Muhamad Alhaj Moustafa, MD ~ Paraneoplastic Frosted Branch Angiitis as First Sign of Relapsed Hodgkin Lymphoma
  • Ollie Anum, PharmD ~ Review on kie-C19 Cellular immunotherapy in adults, relapsed or refractory large B-cell lymphoma
  • Diana Saravia, MD ~ Clinical Outcomes in Hispanic Patients with Metastatic Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors
  • Yen Tran, MBA ~ Medication use evaluation of intravenous acetaminophen among patients in the hematology and oncology unit at Memorial Hospital West in Pembroke Pines, Florida


© 2021 FLASCO | Premium Website Design by The HDG